Biological constraints on GWAS SNPs at suggestive significance thresholds reveal additional BMI loci
Reza K Hammond,
Matthew C Pahl,
Chun Su,
Diana L Cousminer,
Michelle E Leonard,
Sumei Lu,
Claudia A Doege,
Yadav Wagley,
Kenyaita M Hodge,
Chiara Lasconi,
Matthew E Johnson,
James A Pippin,
Kurt D Hankenson,
Rudolph L Leibel,
Alessandra Chesi,
Andrew D Wells,
Struan FA Grant
Affiliations
Reza K Hammond
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
Matthew C Pahl
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
Chun Su
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
Diana L Cousminer
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
Michelle E Leonard
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
Sumei Lu
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
Claudia A Doege
Naomi Berrie Diabetes Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, United States; Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, United States; Columbia Stem Cell Initiative, Vagelos College of Physicians and Surgeons, Columbia University, New York, United States
Yadav Wagley
Department of Orthopaedic Surgery, University of Michigan Medical School, Ann Arbor, United States
Kenyaita M Hodge
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
Matthew E Johnson
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
James A Pippin
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
Kurt D Hankenson
Department of Orthopaedic Surgery, University of Michigan Medical School, Ann Arbor, United States
Rudolph L Leibel
Division of Molecular Genetics (Pediatrics) and the Naomi Berrie Diabetes Center, Columbia University Vagelos College of Physicians and Surgeons, New York, United States
Alessandra Chesi
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States
Andrew D Wells
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Department of Pathology, The Children’s Hospital of Philadelphia, Philadelphia, United States; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
Center for Spatial and Functional Genomics, Children’s Hospital of Philadelphia, Philadelphia, United States; Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, United States; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States; Division of Diabetes and Endocrinology, The Children’s Hospital of Philadelphia, Philadelphia, United States
To uncover novel significant association signals (p<5×10−8), genome-wide association studies (GWAS) requires increasingly larger sample sizes to overcome statistical correction for multiple testing. As an alternative, we aimed to identify associations among suggestive signals (5 × 10−8≤p<5×10−4) in increasingly powered GWAS efforts using chromatin accessibility and direct contact with gene promoters as biological constraints. We conducted retrospective analyses of three GIANT BMI GWAS efforts using ATAC-seq and promoter-focused Capture C data from human adipocytes and embryonic stem cell (ESC)-derived hypothalamic-like neurons. This approach, with its extremely low false-positive rate, identified 15 loci at p<5×10−5 in the 2010 GWAS, of which 13 achieved genome-wide significance by 2018, including at NAV1, MTIF3, and ADCY3. Eighty percent of constrained 2015 loci achieved genome-wide significance in 2018. We observed similar results in waist-to-hip ratio analyses. In conclusion, biological constraints on sub-significant GWAS signals can reveal potentially true-positive loci for further investigation in existing data sets without increasing sample size.